drug

ABBV-1042

1 story · latest Oct 16, 2026

Follow ABBV-1042. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by AbbVie

Timeline

AbbVie's CANASA label update and ABBV-253 trial recruitment lead busy week of registry changes

Oct 16Weekly roundup, 9 itemsABBV-1042 ABBV-253Updated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.